Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01587183 · ClinicalTrials.gov registry record · NA

Running Against Prehypertension Trial (RAPT): A Pilot Trial

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
22
Enrollment target

NCT01587183 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 22 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01587183, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target

Study Summary

This study will test strategies to help people with prehypertension adopt a running program to reduce their blood pressure in the long term. This study will be a 12 week intervention of about 40 participants randomized to running educational material, group based running instruction, or group based running instruction focused on form and all given the option to use the supplemental mHealth intervention. The purpose of this study is to collect feasibility, acceptability and preliminary efficacy data in preparation for a larger planned NIH-R01 study.

Interventions

  • BEHAVIORAL Educational material control
  • BEHAVIORAL Group running style B
  • BEHAVIORAL Group running style A

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2012-03
Est. Completion 2013-06
Phase NA

What the Registry Record Tells You About NCT01587183

The ClinicalTrials.gov registry entry for NCT01587183 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Educational material control is the first listed.

NCT01587183 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01587183 about?

NCT01587183 is a clinical study titled "Running Against Prehypertension Trial (RAPT): A Pilot Trial". This study will test strategies to help people with prehypertension adopt a running program to reduce their blood pressure in the long term. This study will be a 12 week intervention of about 40 participants randomized to running educational material, group based running instruction, or group based ...

What is the current status of trial NCT01587183?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2012-03. Estimated completion is 2013-06.

What interventions are being tested in trial NCT01587183?

The interventions under investigation include: Educational material control (BEHAVIORAL), Group running style B (BEHAVIORAL), Group running style A (BEHAVIORAL).

Who is sponsoring clinical trial NCT01587183?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.